This HTML5 document contains 187 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n18	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n11	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025746/price-of-originator/
n3	http://linked.opendata.cz/ontology/sukl/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025746/reimbursement/
n13	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025746/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025746/core-reimbursement/
skos	http://www.w3.org/2004/02/skos/core#
n16	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025746/price/
n12	http://linked.opendata.cz/resource/sukl/indgroup/
n15	http://linked.opendata.cz/resource/sukl/packing/
n10	http://linked.opendata.cz/resource/sukl/company/
n19	http://linked.opendata.cz/resource/sukl/active-ingredient/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n17	http://linked.opendata.cz/resource/sukl/registration-state/
n8	http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000389/
xsdh	http://www.w3.org/2001/XMLSchema#
n20	http://linked.opendata.cz/resource/atc/
n9	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0025746

rdf:type

n3:MedicinalProductPackaging

dcterms:title

INVANZ 1 G

skos:notation

0025746

n3:hasATCCode

n20:J01DH03

n3:hasActiveIngredient

n19:ERTAPENEMUM-NATRICUM

n3:hasDefinedDailyDose

n7:ddd

n3:hasDosageForm

n9:INF-PLV-SOL-IVN

n3:hasPackagingSize

1

n3:hasPacking

n15:VIA

n3:hasRegistrationHolder

n10:MSDGB

n3:hasRegistrationState

n17:R

n3:hasRouteOfAdministration

n18:IVN

n3:hasStrength

1GM

n3:hasIndicationGroup

n12:15

n3:hasSpecializationRestriction

n13:ATB

n3:containsDefinedDailyDoses

1.0

n3:hasRegistrationCode

EU/1/02/216/001

n3:hasTitleSupplement

IVN INF PLV SOL 1X1GM

n3:containsUsualTherapeuticalDailyDoses

1

n3:hasBreakMarketingDate

2014-04-25+02:00

n3:hasCoreReimbursementSpecification

n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05 n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01

n3:hasPriceOfOriginatorSpecification

n11:2013-02-01 n11:2013-03-01 n11:2013-01-01 n11:2013-01-05 n11:2013-06-01 n11:2013-07-01 n11:2013-04-01 n11:2013-05-01 n11:2013-09-01 n11:2013-10-01 n11:2013-08-01 n11:2013-08-03 n11:2014-01-01 n11:2014-02-01 n11:2013-11-01 n11:2013-12-01 n11:2014-05-01 n11:2014-06-01 n11:2014-03-01 n11:2014-04-01 n11:2014-07-03 n11:2014-08-01 n11:2014-06-13 n11:2014-07-01 n11:2014-10-02 n11:2014-11-01 n11:2014-09-01 n11:2014-10-01 n11:2015-01-01 n11:2015-01-13 n11:2014-11-19 n11:2014-12-01 n11:2015-04-01 n11:2015-04-02 n11:2015-02-01 n11:2015-03-01 n11:2015-07-01 n11:2015-07-02 n11:2015-05-01 n11:2015-06-01

n3:hasPriceSpecification

n16:2013-01-01 n16:2013-01-05 n16:2013-02-01 n16:2013-03-01 n16:2013-08-01 n16:2013-08-03 n16:2013-09-01 n16:2013-10-01 n16:2013-04-01 n16:2013-05-01 n16:2013-06-01 n16:2013-07-01 n16:2014-03-01 n16:2014-04-01 n16:2014-05-01 n16:2014-06-01 n16:2013-11-01 n16:2013-12-01 n16:2014-01-01 n16:2014-02-01 n16:2014-09-01 n16:2014-10-01 n16:2014-10-02 n16:2014-11-01 n16:2014-06-13 n16:2014-07-01 n16:2014-07-03 n16:2014-08-01 n16:2015-02-01 n16:2015-03-01 n16:2015-04-01 n16:2015-04-02 n16:2014-11-19 n16:2014-12-01 n16:2015-01-01 n16:2015-01-13 n16:2015-05-01 n16:2015-06-01 n16:2015-07-01 n16:2015-07-02

n3:hasReimbursementSpecification

n5:2014-06-13 n5:2014-07-01 n5:2015-04-01 n5:2015-04-02 n5:2015-02-01 n5:2015-03-01 n5:2015-01-01 n5:2015-01-13 n5:2014-11-19 n5:2014-12-01 n5:2015-07-01 n5:2015-07-02 n5:2015-05-01 n5:2015-06-01 n5:2013-02-01 n5:2013-03-01 n5:2013-01-01 n5:2013-01-05 n5:2013-09-01 n5:2013-10-01 n5:2013-08-01 n5:2013-08-03 n5:2013-06-01 n5:2013-07-01 n5:2013-04-01 n5:2013-05-01 n5:2014-05-01 n5:2014-06-01 n5:2014-03-01 n5:2014-04-01 n5:2014-01-01 n5:2014-02-01 n5:2013-11-01 n5:2013-12-01 n5:2014-10-02 n5:2014-11-01 n5:2014-09-01 n5:2014-10-01 n5:2014-07-03 n5:2014-08-01

n3:hasResumedMarketingDate

2014-05-22+02:00 2003-07-01+02:00

n3:hasUsualTherapeuticalDailyDose

n7:utdd

n3:pilFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000389%2FWC500033921.pdf

n3:pilUri

n8:WC500033921.pdf

n3:spcFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000389%2FWC500033921.pdf

n3:spcUri

n8:WC500033921.pdf